Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mediastinal gray zone lymphoma.

Literature DB >> 21454881

Mediastinal gray zone lymphoma.

Leticia Quintanilla-Martinez, Falko Fend.

Abstract

Entities: Disease

Mesh：

Year: 2011 PMID： 21454881 PMCID： PMC3069224 DOI： 10.3324/haematol.2011.043026

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

× No keyword cloud information.

17 in total

1. Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells.

Authors: S Joos; M Küpper; S Ohl; F von Bonin; G Mechtersheimer; M Bentz; P Marynen; P Möller; M Pfreundschuh; L Trümper; P Lichter
Journal: Cancer Res Date: 2000-02-01 Impact factor: 12.701

2. Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression.

Authors: Alexey Ushmorov; Olga Ritz; Michael Hummel; Frank Leithäuser; Peter Möller; Harald Stein; Thomas Wirth
Journal: Blood Date: 2004-07-29 Impact factor: 22.113

3. Classical Hodgkin's disease. Clinical impact of the immunophenotype.

Authors: R von Wasielewski; M Mengel; R Fischer; M L Hansmann; K Hübner; J Franklin; H Tesch; U Paulus; M Werner; V Diehl; A Georgii
Journal: Am J Pathol Date: 1997-10 Impact factor: 4.307

4. Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma.

Authors: Franziska C Eberle; Jaime Rodriguez-Canales; Lai Wei; Jeffrey C Hanson; J Keith Killian; Hong-Wei Sun; Lisa G Adams; Stephen M Hewitt; Wyndham H Wilson; Stefania Pittaluga; Paul S Meltzer; Louis M Staudt; Michael R Emmert-Buck; Elaine S Jaffe
Journal: Haematologica Date: 2011-04 Impact factor: 9.941

5. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma.

Authors: Alexandra Traverse-Glehen; Stefania Pittaluga; Philippe Gaulard; Lynn Sorbara; Miguel A Alonso; Mark Raffeld; Elaine S Jaffe
Journal: Am J Surg Pathol Date: 2005-11 Impact factor: 6.394

6. Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation.

Authors: P Möller; G Moldenhauer; F Momburg; B Lämmler; M Eberlein-Gonska; S Kiesel; B Dörken
Journal: Blood Date: 1987-04 Impact factor: 22.113

7. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

Authors: Kerry J Savage; Stefano Monti; Jeffery L Kutok; Giorgio Cattoretti; Donna Neuberg; Laurence De Leval; Paul Kurtin; Paola Dal Cin; Christine Ladd; Friedrich Feuerhake; Ricardo C T Aguiar; Sigui Li; Gilles Salles; Francoise Berger; Wen Jing; Geraldine S Pinkus; Thomas Habermann; Riccardo Dalla-Favera; Nancy Lee Harris; Jon C Aster; Todd R Golub; Margaret A Shipp
Journal: Blood Date: 2003-08-21 Impact factor: 22.113

Review 8. Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma).

Authors: T Rüdiger; E S Jaffe; G Delsol; C deWolf-Peeters; R D Gascoyne; A Georgii; N L Harris; M E Kadin; K A MacLennan; S Poppema; H Stein; L E Weiss; H K Müller-Hermelink
Journal: Ann Oncol Date: 1998 Impact factor: 32.976

9. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.

Authors: Stefano A Pileri; Gianluca Gaidano; Pier Luigi Zinzani; Brunangelo Falini; Philippe Gaulard; Emanuele Zucca; Federica Pieri; Eva Berra; Elena Sabattini; Stefano Ascani; Milena Piccioli; Peter W M Johnson; Roberto Giardini; Edoardo Pescarmona; Domenico Novero; Pier Paolo Piccaluga; Teresa Marafioti; Miguel A Alonso; Franco Cavalli
Journal: Am J Pathol Date: 2003-01 Impact factor: 4.307

10. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.

Authors: Andreas Rosenwald; George Wright; Karen Leroy; Xin Yu; Philippe Gaulard; Randy D Gascoyne; Wing C Chan; Tong Zhao; Corinne Haioun; Timothy C Greiner; Dennis D Weisenburger; James C Lynch; Julie Vose; James O Armitage; Erlend B Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Elias Campo; Emili Montserrat; Armando Lopez-Guillermo; German Ott; H Konrad Muller-Hermelink; Joseph M Connors; Rita Braziel; Thomas M Grogan; Richard I Fisher; Thomas P Miller; Michael LeBlanc; Michael Chiorazzi; Hong Zhao; Liming Yang; John Powell; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; Louis M Staudt
Journal: J Exp Med Date: 2003-09-15 Impact factor: 14.307

6 in total

1. Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association.

Authors: Clémentine Sarkozy; Thierry Molina; Hervé Ghesquières; Anne-Sophie Michallet; Jehan Dupuis; Diane Damotte; Franck Morsschauser; Marie Parrens; Laurent Martin; Peggy Dartigues; Aspasia Stamatoullas; Pierre Hirsch; Bettina Fabiani; Krimo Bouabdallah; Maria Gomes da Silva; Marie Maerevoet; Camille Laurent; Bertrand Coiffier; Gilles Salles; Alexandra Traverse-Glehen
Journal: Haematologica Date: 2016-10-06 Impact factor: 9.941

2. Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma.

Authors: Dai Chihara; Jason R Westin; Roberto N Miranda; Chan Y Cheah; Yasuhiro Oki; Francesco Turturro; Jorge E Romaguera; Sattva S Neelapu; Lorreta J Nastoupil; Luis E Fayad; M Alma Rodriguez; Nathan H Fowler; Robert Z Orlowski; Michael Wang; Fredrick B Hagemeister; L Jeffrey Medeiros; Michelle A Fanale
Journal: Br J Haematol Date: 2016-07-05 Impact factor: 6.998